COMMENTARY: Galantamine was effective in mild-to-moderate Alzheimer disease

Hirsch, Calvin
September 2006
ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p50
Academic Journal
The article presents the author's comment on researcher K. Rockwood and colleagues' study on the effectiveness of galantamine in mild-to-moderate Alzheimer disease. Rockwood and colleagues identified that patient or caregiver wishes to change dementia-related problems. Clinician-based goal attainment scaling and the Alzheimer disease assessment scale showed significant improvement in patients by the intake of galantamine.


Related Articles

  • Project study to look at managed care role. Santiago, Raquel // Crain's Cleveland Business;04/27/98, Vol. 19 Issue 17, p9 

    Presents information on a study which looks at the role of managed care, relating to the quality and cost of caring for patients with Alzheimer's disease and dementia, by the Cleveland Area Alzheimer's Association and Kaiser Permanente. Reference to the financing of the study through grants;...

  • Updating the Nation's Roadmap to Treat Alzheimer's Disease. MATHENY, Helen // State Journal (WV);8/30/2013, Vol. 29 Issue 34, p37 

    The article argues against the increase of medical care costs for patients with Alzheimer's disease in the U.S.

  • Westchester faces a tsunami of Alzheimer's disease. MABIJ, RITA // Westchester County Business Journal;2/1/2016, Vol. 52 Issue 5, p18 

    The article reports that Westchester County, New York, is witnessing a surge in Alzheimer's disease, which affects more than 5.3 million Americans, including more than 1 in 10 residents who are 65 or older. The Hudson Valley chapter of the Alzheimer's Association estimates about 40,000 people...

  • The 'Hidden' Victims of Alzheimer's Disease. Ullman, Terry // FDA Consumer;Jul/Aug2003, Vol. 37 Issue 4, p40 

    Deals with the impact of Alzheimer's disease on individuals caring for patients with the disease. Reaction of families when they first receive a diagnosis of the disease; Threat posed by the disease to individuals infected; Need to give assistance to patients with Alzheimer's.

  • Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial. Rockwood, Kenneth; Fay, Sherri; Xiaowei Song; MacKnight, Chris; Gorman, Mary // CMAJ: Canadian Medical Association Journal;4/11/2006, Vol. 174 Issue 8, p1099 

    Background: Although cholinesterase inhibitors have produced statistically significant treatment effects, their clinical meaningfulness in Alzheimer's disease is disputed. An important aspect of clinical meaningfulness is the extent to which an intervention meets the goals of treatment. Methods:...

  • An innovative approach to involve patients in measuring treatment effects in drug trials. Kaduszkiewicz, Hanna // CMAJ: Canadian Medical Association Journal;4/11/2006, Vol. 174 Issue 8, p1117 

    The article comments on the results of a randomized controlled double-blind trial of the cholinesterase inhibitor galantamine conducted by Rockwood et al. The trial was made for patients with Alzheimer's disease. The procedures for conducting the study are presented. The use of the Goal...

  • Individualized outcome measures for evaluating life skill groups for children with disabilities. Rezze, Briano Di; Wright, Virginia; Curran, C. J.; Campbell, Kent A.; Macarthur, Colin // Canadian Journal of Occupational Therapy;Dec2008, Vol. 75 Issue 5, p282 

    The article focuses on a study which examined the feasibility and utility of goat menus and individualized outcome measures in two life skill groups for children with disabilities. The study included 11 children who were evaluated at baseline and five weeks post-program using the modified...

  • The Prevention and Reactivation Care Program: intervention fidelity matters. de Vos, Annemarie J. B. M.; Bakker, Ton J. E. M.; de Vreede, Paul L.; van Wijngaarden, Jeroen D. H.; Steyerberg, Ewout W.; Mackenbach, Johan P.; Nieboer, Anna P. // BMC Health Services Research;2013, Vol. 13 Issue 1, p1 

    Background: The Prevention and Reactivation Care Program (PReCaP) entails an innovative multidisciplinary, integrated and goal oriented approach aimed at reducing hospital related functional decline among elderly patients. Despite calls for process evaluation as an essential component of...

  • Goal attainment scaling: a direct comparison of alternative rating methods. Turner-Stokes, Lynne; Williams, Heather // Clinical Rehabilitation;Jan2010, Vol. 24 Issue 1, p66 

    Purpose: To compare two alternative rating systems for goal attainment scaling (GAS) intended to improve capture of goal underachievement. Setting: A tertiary inpatient neurorehabilitation unit. Design: Secondary comparative analysis of prospective cohort data. Participants: A total of 243...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics